Research ArticleClinical Investigation
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
Daniel Gillett, Russell Senanayake, James MacFarlane, Waiel Bashari, August Palma, Lihua Hu, Ines Harper, Iosif A. Mendichovszky, Gunnar Antoni, Per Hellman, Anders Sundin, Matthew Hird, István Boros, Morris J. Brown, Heok Cheow, Luigi Aloj, Franklin Aigbirhio and Mark Gurnell
Journal of Nuclear Medicine March 2025, 66 (3) 434-440; DOI: https://doi.org/10.2967/jnumed.124.268425
Daniel Gillett
1Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom;
2Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom;
Russell Senanayake
1Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom;
James MacFarlane
1Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom;
Waiel Bashari
1Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom;
August Palma
1Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom;
Lihua Hu
1Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom;
Ines Harper
2Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom;
Iosif A. Mendichovszky
2Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom;
3Department of Radiology, University of Cambridge, Cambridge, United Kingdom;
Gunnar Antoni
4Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
Per Hellman
5Department of Surgical Sciences, Uppsala University, Uppsala, Sweden;
Anders Sundin
5Department of Surgical Sciences, Uppsala University, Uppsala, Sweden;
Matthew Hird
6Molecular Imaging Chemistry Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom;
István Boros
7Radiopharmaceutical Unit, Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, United Kingdom; and
Morris J. Brown
8Department of Endocrinology, Queen Mary University of London, London, United Kingdom
Heok Cheow
2Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom;
Luigi Aloj
2Department of Nuclear Medicine, Addenbrooke’s Hospital, Cambridge, United Kingdom;
3Department of Radiology, University of Cambridge, Cambridge, United Kingdom;
Franklin Aigbirhio
6Molecular Imaging Chemistry Laboratory, Wolfson Brain Imaging Centre, Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom;
7Radiopharmaceutical Unit, Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, United Kingdom; and
Mark Gurnell
1Cambridge Endocrine Molecular Imaging Group, Institute of Metabolic Science, University of Cambridge, Cambridge, United Kingdom;

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
SNMMI members
Login to the site using your SNMMI member credentials
Individuals
Login as an individual user
In this issue
Journal of Nuclear Medicine
Vol. 66, Issue 3
March 1, 2025
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
Daniel Gillett, Russell Senanayake, James MacFarlane, Waiel Bashari, August Palma, Lihua Hu, Ines Harper, Iosif A. Mendichovszky, Gunnar Antoni, Per Hellman, Anders Sundin, Matthew Hird, István Boros, Morris J. Brown, Heok Cheow, Luigi Aloj, Franklin Aigbirhio, Mark Gurnell
Journal of Nuclear Medicine Mar 2025, 66 (3) 434-440; DOI: 10.2967/jnumed.124.268425
A Phase I/IIa Clinical Trial to Evaluate Safety and Adrenal Uptake of Para-Chloro-2-[18F]Fluoroethyletomidate in Healthy Volunteers and Patients with Primary Aldosteronism
Daniel Gillett, Russell Senanayake, James MacFarlane, Waiel Bashari, August Palma, Lihua Hu, Ines Harper, Iosif A. Mendichovszky, Gunnar Antoni, Per Hellman, Anders Sundin, Matthew Hird, István Boros, Morris J. Brown, Heok Cheow, Luigi Aloj, Franklin Aigbirhio, Mark Gurnell
Journal of Nuclear Medicine Mar 2025, 66 (3) 434-440; DOI: 10.2967/jnumed.124.268425
Jump to section
Related Articles
Cited By...
- No citing articles found.